ClinicalTrials.gov record
Completed No phase listed Observational

Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry

ClinicalTrials.gov ID: NCT02271022

Public ClinicalTrials.gov record NCT02271022. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02271022
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
AstraZeneca
Industry
Enrollment
2,000 participants

Conditions and interventions

Interventions

  • Non-Interventional Study Other

Other

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 16, 2015
Primary completion
Oct 30, 2019
Completion
Oct 30, 2019
Last update posted
Nov 2, 2020

2015 – 2019

United States locations

U.S. sites
55
U.S. states
26
U.S. cities
48
Facility City State ZIP Site status
Research Site Birmingham Alabama 35233
Research Site Mobile Alabama 36688
Research Site Little Rock Arkansas 72211
Research Site Sacramento California 95812
Research Site Bridgeport Connecticut 06610
Research Site Hartford Connecticut 06102
Research Site Washington D.C. District of Columbia 20036
Research Site Gainesville Florida 32603
Research Site Hialeah Florida 33016
Research Site Miami Florida 33136
Research Site Tampa Florida 33606
Research Site Atlanta Georgia 30322
Research Site Macon Georgia 31217
Research Site Peoria Illinois 61614
Research Site Richmond Indiana 47374
Research Site Baltimore Maryland 20814
Research Site Baltimore Maryland 21215
Research Site Baltimore Maryland 21287
Research Site Boston Massachusetts 02115
Research Site Worcester Massachusetts 06105
Research Site Bloomfield Michigan 48323
Research Site Grand Blanc Michigan 48439
Research Site Royal Oak Michigan 48073
Research Site Duluth Minnesota 55805
Research Site Saint Paul Minnesota 55101
Research Site Kansas City Missouri 64106
Research Site Kansas City Missouri 64111
Research Site Kansas City Missouri 64116
Research Site Springfield Missouri 65807
Research Site Camden New Jersey 08103
Research Site Flemington New Jersey 08822
Research Site Newark New Jersey 07102
Research Site Piscataway New Jersey 08854
Research Site Teaneck New Jersey 07666
Research Site Brooklyn New York 11215
Research Site New York New York 10029
Research Site New York New York 11235
Research Site Durham North Carolina 27710
Research Site Cleveland Ohio 44195
Research Site Oklahoma City Oklahoma 73135
Research Site Roseburg Oregon 97471
Research Site Philadelphia Pennsylvania 19107
Research Site Philadelphia Pennsylvania 19141
Research Site York and Ephrata Pennsylvania 17403
Research Site Memphis Tennessee 37920
Research Site Memphis Tennessee 38120
Research Site Nashville Tennessee 37203
Research Site Dallas Texas 75246
Research Site Galveston Texas 77550
Research Site McKinney Texas 75069
Research Site New Braunfels Texas 78132
Research Site Charlottesville Virginia 22903
Research Site Tacoma Washington 98405
Research Site Manitowoc Wisconsin 54221
Research Site Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02271022, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2020 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02271022 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →